Releases
Found 20944 articles
New Brain Mapping Reveals LM11A-31 Impact on Alzheimer’s Networks
A new analysis presented at the Alzheimer's Association International Conference suggests that the experimental drug LM11A-31 may preserve vital communication networks in the brains of patients with mild-to-moderate Alzheimer's disease, offering a potential path to slowing cognitive decline through the stabilization of synaptic resilience.
Red Cross Declares Emergency as Blood Supplies Plunge 25 Percent
With national blood reserves falling by a quarter in June, the American Red Cross has officially declared an emergency shortage. The decline, driven by the seasonal loss of school-based blood drives and summer travel, leaves trauma centers and maternity wards scrambling to maintain life-saving operations for critical patients.
Via Transportation Faces Class Action Lawsuit Over IPO Disclosures
Investors who purchased Via Transportation, Inc. securities following the company’s September 2025 initial public offering are being urged to join a class action lawsuit. The Schall Law Firm alleges the company misled shareholders regarding its financial health and the stability of its expansion efforts in Germany.
Verra Mobility Faces Class Action Over Alleged Customer Loss Concealment
Investors who purchased Verra Mobility Corporation stock between February 24 and May 26, 2026, are being urged to join a securities class action lawsuit. The Schall Law Firm alleges the company misled shareholders regarding its growth prospects and the stability of its vital relationship with Avis Budget Group.
INTCO Medical Accelerates Carbon Cuts to Meet 2050 Neutrality Goal
Number: Carbon emissions per glove at INTCO Medical dropped to 18.14 grams of CO2 equivalent in 2025, an 11.14% year-over-year decline that puts the manufacturer 32.5% below its 2022 baseline and well ahead of its 2030 reduction targets as the firm pushes toward full carbon neutrality by 2050.
Leads Biolabs to Present Six Oncology Studies at ESMO 2026
Nanjing-based Leads Biolabs has secured six research slots at the upcoming European Society for Medical Oncology Annual Congress in Madrid, including two high-profile oral presentations. The selection signals growing international interest in the firm's pipeline, particularly its pan-tumor immunotherapy candidate, Opamtistomig, and its GPRC5D-targeting T-cell engager, LBL-034.
Boostimmune Secures Japanese Patent for TCTP-Targeting Cancer Therapy
Seoul-based Boostimmune has secured a Japanese patent for a novel immuno-oncology technology that prevents the accumulation of myeloid-derived suppressor cells (MDSCs) within tumors. By neutralizing translationally controlled tumor protein (TCTP) released by dying cancer cells, the therapy aims to restore the immune system’s ability to attack malignant growths.
GeneDx Faces Securities Class Action Over Alleged Misleading Statements
Investors who held GeneDx Holdings Corp. shares between April 16, 2025, and May 4, 2026, are being urged to join a class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act, centered on claims that the company misled the market regarding its financial health and earnings potential.
Erica Silverglide Launches Ignite Collection Featuring Rare Fluorescent Gems
After two decades of sourcing stones for luxury brands, gemologist Erica Silverglide is stepping into the spotlight with Ignite. The debut collection from her brand, GemologyGeek, pivots away from mass-market jewelry by focusing on one-of-a-kind pieces that highlight the rare, natural phenomenon of diamond fluorescence.
Investors Target Futu Holdings in Securities Class Action
Investors who purchased Futu Holdings Limited shares between May 24, 2023, and May 27, 2026, face an August 25 deadline to join a class action lawsuit. The litigation alleges the company misled shareholders regarding its regulatory standing and licensing requirements within the Chinese market.
Investors File Securities Class Action Against GRAIL
A federal class action lawsuit now targets GRAIL, Inc. following allegations that the biotechnology firm misled shareholders regarding the results of its NHS-Galleri clinical trial. The litigation, filed under the Securities Exchange Act, covers investors who acquired shares between May 13, 2025, and February 19, 2026.
Hub Group Faces Class Action Lawsuit Over Alleged Financial Misstatements
Investors who purchased Hub Group, Inc. shares between April 28, 2023, and May 11, 2026, are being urged to join a securities class action lawsuit. Filed by the DJS Law Group, the complaint alleges the company provided false financial data, including inflated revenue recognition and operating income figures.
Investors Face August 4 Deadline in PicS N.V. Securities Class Action
Investors who purchased PicS N.V. Class A common stock during the company’s January 2026 initial public offering have until August 4, 2026, to seek appointment as lead plaintiff in a federal class action lawsuit filed against the Brazilian digital bank and its top executives.
Peabody Energy Faces Class Action Over Centurion Mine Disclosures
Investors who held Peabody Energy stock between October 2024 and May 2026 are facing a potential financial reckoning after a class action lawsuit alleged the company misled the market regarding the production trajectory of its Centurion mine. The legal action centers on claims of material misstatements regarding operational progress.
Photronics Faces Class Action Lawsuit Over Alleged Misleading Statements
Investors who purchased Photronics, Inc. shares between December 10, 2025, and May 27, 2026, are being urged to join a class action lawsuit. The DJS Law Group filed the action, alleging that the company misled the market regarding the strength of its high-end product pipeline and business momentum.
AeroVironment Faces Class Action Lawsuit Over Alleged Market Misleading
Investors who purchased AeroVironment, Inc. stock between June 25, 2025, and March 10, 2026, are being urged to contact DJS Law Group regarding a securities class action. The lawsuit alleges that the company misled shareholders concerning its competitive standing for U.S. Space Force contracts.
Laura Chaubard to Lead Sopra Steria’s Defence and Space Division
Laura Chaubard, the former Director General of École Polytechnique and a General Engineer of Armament, will assume leadership of Sopra Steria’s Defence, Security and Space vertical on September 1, 2026. Her appointment signals a shift toward bolstering European technological sovereignty amid surging regional military spending.
Investors Launch Securities Class Action Against Badger Meter
Shareholders of Badger Meter, Inc. have initiated a class action lawsuit alleging the company misled the market regarding its financial health. The complaint claims the firm artificially bolstered its performance by pulling forward customer orders while publicly attributing success to sustainable growth drivers during the period from April 2024 to April 2026.
ADMA Biologics Faces Class Action Over Alleged Securities Violations
Investors who purchased ADMA Biologics stock between August 9, 2024, and March 25, 2026, are being urged to join a class action lawsuit. The DJS Law Group is spearheading the litigation, alleging that the company misled the market regarding its financial health and internal sales practices.
BitGo Holdings Faces Class Action Over IPO Disclosures
Investors who purchased BitGo Holdings stock following the company’s January 22, 2026, initial public offering are now part of a federal securities class action. The lawsuit alleges that BitGo misled the market by inflating its financial outlook while obscuring the impact of declining digital asset prices on its operations.
.jpg)
Black Rock Coffee Faces Securities Lawsuit Over Growth Claims
Investors who purchased Black Rock Coffee Bar shares between September 12, 2025, and May 12, 2026, are being urged to join a class action lawsuit. The litigation targets the company for allegedly issuing misleading statements regarding its store expansion strategy and the impact of new locations on existing performance.
Investors Initiate Class Action Against Calix Over Margin Misstatements
Investors who purchased Calix, Inc. shares between January 28 and April 21, 2026, face a July 27 deadline to join a class action lawsuit. The litigation alleges the company issued misleading public statements regarding its quarterly performance and the impact of memory module procurement on its bottom line.
Investors Urged to Join GeneDx Securities Fraud Class Action
The Schall Law Firm is rallying investors to participate in a class action lawsuit against GeneDx Holdings Corp. following allegations of misleading financial disclosures. Shareholders who acquired securities between April 16, 2025, and May 4, 2026, have until August 3, 2026, to join the litigation regarding potential violations of federal securities laws.
Laura Chaubard to lead Sopra Steria’s Defence, Security and Space unit
Laura Chaubard, the former Director General of École Polytechnique, will oversee Sopra Steria’s Defence, Security and Space vertical starting September 1, 2026. Her transition to the Group Executive Committee signals a strategic push to deepen the firm’s influence in European sovereign technology and critical infrastructure.
Erasca Faces Class Action Lawsuit Over Misleading Drug Development Claims
Investors who purchased Erasca, Inc. shares between January 14, 2025, and April 26, 2026, are being urged to join a class action lawsuit. The litigation, filed by the DJS Law Group, alleges that the company violated federal securities laws by misrepresenting the patent status and viability of its ERAS-0015 drug candidate.
Embecta Faces Class Action Lawsuit Over Alleged Securities Violations
Investors who purchased Embecta Corp. stock between November 25, 2025, and May 4, 2026, are being urged to join a class action lawsuit. The DJS Law Group filed the action alleging that the company misled shareholders regarding the stability of its fiscal guidance and market challenges.
Investors Target First Solar in Securities Fraud Class Action
The DJS Law Group has opened a class action lawsuit against First Solar, Inc., alleging the company misled shareholders regarding its manufacturing shift from Asia to the United States. The complaint centers on claims that the solar manufacturer misrepresented its ability to navigate international trade tariffs throughout 2025.
L'Oréal and Louis Theroux Headline UNLEASH Paris HR Summit
Eight thousand five hundred senior leaders from 140 countries will converge at the Paris Convention Centre this October to address a singular challenge: how to fundamentally reinvent the nature of work in the age of artificial intelligence for a collective workforce exceeding 100 million employees.
Gerald Group Secures US$50 Million ECI-Backed Financing Facility
Geneva-based commodity trader Gerald Group has closed a US$50 million, three-year finance facility backed by Etihad Credit Insurance, marking its first export credit agency-supported financing in the region. The deal, arranged through Abu Dhabi Commercial Bank, aims to bolster non-oil metals trade flows originating from the United Arab Emirates.
L'Oréal and Louis Theroux Headline UNLEASH Paris HR Summit
With 8,500 senior leaders representing 100 million global employees converging on the Paris Convention Centre from October 20–22, 2026, the UNLEASH conference marks a definitive shift toward AI-driven organizational design, moving beyond automation to embrace a new category of enterprise-wide work technology.